Stratec SE
Jonathan Galaska has extensive experience in business development, sales, and strategic account management. Jonathan currently holds the position of Senior Vice President at STRATEC SE. Prior to this, they served as a Senior Strategic Account Executive at Scapa Healthcare, where they played a crucial role in revenue growth and client relationship management. Jonathan also held various roles at Dymax Corporation, including Global Account Manager, Territory Manager, Program Manager, Market Segment Specialist, Applications Engineer, and Technical Service Engineer, demonstrating their diverse skill set and adaptability in different areas of the industry.
Jonathan Galaska holds a Bachelor's degree in Engineering & Business from the University of Connecticut, which they completed from 1999 to 2003. In 2012, they completed the Sales Advantage program at Dale Carnegie Training. Jonathan pursued an Intro to Improvisation (Improv) program at The Second City in 2015 and completed the Strategic Selling program at Miller-Heiman in 2018.
This person is not in any offices
Stratec SE
Stratec SE is a Germany-based company engaged in the development and manufacture of fully automated systems based on its own patented technologies for its partners in the fields of in-vitro diagnostics and life sciences in Germany and internationally. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.